Free Trial
NASDAQ:XRTX

XORTX Therapeutics Q4 2024 Earnings Report

XORTX Therapeutics EPS Results

Actual EPS
$0.04
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

XORTX Therapeutics Revenue Results

Actual Revenue
N/A
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

XORTX Therapeutics Announcement Details

Quarter
Q4 2024
Time
After Market Closes
Conference Call Date
Wednesday, March 26, 2025
Conference Call Time
5:00PM ET

XORTX Therapeutics Earnings Headlines

Trump’s betrayal exposed
Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to move your money now.tc pixel
XORTX Initiates IND Preparation for XORLO™ in Gout Program
See More XORTX Therapeutics Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like XORTX Therapeutics? Sign up for Earnings360's daily newsletter to receive timely earnings updates on XORTX Therapeutics and other key companies, straight to your email.

About XORTX Therapeutics

Xyratex Ltd (Xyratex) is a provider of data storage technology, including modular solutions for the enterprise data storage industry and hard disk drive (HDD) capital equipment for the HDD industry. Xyratex operates in two segments: Networked Storage Solutions (NSS) and Storage Infrastructure (SI). Its NSS products are primarily HDD based data storage subsystems and solutions, which it provides to original equipment manufacturers. Its SI products consist of HDD manufacturing process equipment, which it sells directly to manufacturers of HDDs and their component suppliers. Its product and solution portfolio for the enterprise data storage industry includes storage enclosures, integrated application platforms and high performance computing (HPC) data storage solutions. In April 2014, Seagate Technology PLC completed the acquisition of Xyratex Ltd.

View XORTX Therapeutics Profile

More Earnings Resources from MarketBeat